These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 23861632)
1. Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndrome. Smith HS; Bracken D; Smith JM J Cent Nerv Syst Dis; 2010; 2():57-72. PubMed ID: 23861632 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for fibromyalgia. Smith HS; Bracken D; Smith JM Front Pharmacol; 2011; 2():17. PubMed ID: 21772818 [TBL] [Abstract][Full Text] [Related]
3. Duloxetine for the management of fibromyalgia syndrome. Scholz BA; Hammonds CL; Boomershine CS J Pain Res; 2009 Jul; 2():99-108. PubMed ID: 21197298 [TBL] [Abstract][Full Text] [Related]
5. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. Recla JM J Pain Res; 2010 Jul; 3():89-103. PubMed ID: 21197313 [TBL] [Abstract][Full Text] [Related]
6. Role and rationale for the use of milnacipran in the management of fibromyalgia. Kranzler JD; Gendreau RM Neuropsychiatr Dis Treat; 2010 May; 6():197-208. PubMed ID: 20520784 [TBL] [Abstract][Full Text] [Related]
7. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Mease PJ Am J Med; 2009 Dec; 122(12 Suppl):S44-55. PubMed ID: 19962496 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Lee YH; Song GG Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046 [TBL] [Abstract][Full Text] [Related]
10. Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis. Lian YN; Wang Y; Zhang Y; Yang CX Int J Neurosci; 2020 Jan; 130(1):71-82. PubMed ID: 31487217 [No Abstract] [Full Text] [Related]
11. Advances in diagnostic and treatment options in patients with fibromyalgia syndrome. Gur A; Oktayoglu P Open Access Rheumatol; 2009; 1():193-209. PubMed ID: 27789991 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia. White C; Kwong WJ; Armstrong H; Behling M; Niemira J; Lang K Am Health Drug Benefits; 2018 Sep; 11(6):293-301. PubMed ID: 30464796 [TBL] [Abstract][Full Text] [Related]
13. New treatment options for fibromyalgia: critical appraisal of duloxetine. Uçeyler N; Offenbächer M; Petzke F; Häuser W; Sommer C Neuropsychiatr Dis Treat; 2008 Jun; 4(3):525-9. PubMed ID: 18830399 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of fibromyalgia syndrome: new developments. Staud R Drugs; 2010; 70(1):1-14. PubMed ID: 20030422 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of fibromyalgia. Traynor LM; Thiessen CN; Traynor AP Am J Health Syst Pharm; 2011 Jul; 68(14):1307-19. PubMed ID: 21719591 [TBL] [Abstract][Full Text] [Related]
16. Sodium oxybate for the treatment of fibromyalgia. Staud R Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091 [TBL] [Abstract][Full Text] [Related]
17. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant. Keks NA; Hope J; Keogh S; Copolov DL Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305 [TBL] [Abstract][Full Text] [Related]
18. Tramadol for the treatment of fibromyalgia. MacLean AJ; Schwartz TL Expert Rev Neurother; 2015 May; 15(5):469-75. PubMed ID: 25896486 [TBL] [Abstract][Full Text] [Related]